Google
×
United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases.
Investor Resources for Pharmaceutical and Biotech Investment at United Therapeutics Corporation.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Head of Investor Relations, N/A, N/A, N/A. Ms. Holly Hobson, Associate Vice President of Human Resources, N/A, N/A, N/A. Kevin T. Gray, Senior Vice President of ...
UTHR - key executives, insider trading, ownership, revenue and average growth rates ... Head-Investor Relations, United Therapeutics Corp. ... UTHR. Significant ...
To inspect the list, please email our Investor Relations department at IR@unither.com. By Order of the Board of Directors,. PAUL A. MAHON Corporate Secretary
... investing for the long-haul, we have you covered. Delivered Mondays. All Text Fields Are Required. Thanks for submitting! Investor Relations ˇ Contact ˇ Careers ...
Feb 21, 2024 ˇ United Therapeutics Corporation (UTHR) Q4 2023 Earnings Call Transcript ... Investor Relations website at ir.unither.com. ... More on UTHR. United ...
QuantumOnline.com offers complete income investment security information for individual investors seeking regular returns on investments.
See the latest United Therapeutics Corp stock price (UTHR:XNAS), related news, valuation, dividends and more to help you make your investing decisions.